Quaterly Results | Gufic Biosciences Ltd. | R Wadiwala Securities Pvt Ltd

GUFIC BIOSCIENCES LTD.

NSE : GUFICBIOBSE : 509079ISIN CODE : INE742B01025Industry : Pharmaceuticals & DrugsHouse : Private
BSE301.202.5 (+0.84 %)
PREV CLOSE (Rs.) 298.70
OPEN PRICE (Rs.) 302.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2166
TODAY'S LOW / HIGH (Rs.)301.00 305.25
52 WK LOW / HIGH (Rs.)267.5 409
NSE302.852.85 (+0.95 %)
PREV CLOSE( Rs. ) 300.00
OPEN PRICE (Rs.) 296.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 26628
TODAY'S LOW / HIGH(Rs.) 296.15 305.70
52 WK LOW / HIGH (Rs.)268 407.85

Quarterly Results

Quarters
Select year
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
2314.10
2370.54
2237.22
2050.20
Total Expenditure
1984.32
1992.09
1904.21
1786.46
PBIDT (Excl OI)
329.78
378.45
333.01
263.74
Other Income
7.90
21.16
9.25
3.94
Operating Profit
337.68
399.61
342.27
267.69
Interest
83.56
95.85
92.34
84.00
Exceptional Items
NA
NA
NA
NA
PBDT
254.12
303.76
249.93
183.69
Depreciation
76.92
77.73
77.19
78.43
Profit Before Tax
177.20
226.03
172.74
105.26
Tax
52.97
57.82
42.04
28.05
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
124.23
168.21
130.70
77.21
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
124.23
168.21
130.70
77.21
Minority Interest
NA
0.01
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
124.24
168.24
130.70
77.20
Equity Capital
100.28
100.28
100.28
100.28
Face Value (IN RS)
1.00
1.00
1.00
1.00
Reserves
NA
NA
NA
NA
Calculated EPS
1.24
1.68
1.30
0.77
Calculated EPS (Annualised)
4.96
6.71
5.21
3.08
No of Public Share Holdings
27574355.00
27574355.00
27569355.00
27569355.00
% of Public Share Holdings
27.49
27.50
27.48
27.49
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
14.25
15.96
14.88
12.86
PBIDTM%
14.59
16.86
15.30
13.06
PBDTM%
10.98
12.81
11.17
8.96
PBTM%
7.66
9.53
7.72
5.13
PATM%
5.37
7.10
5.84
3.77
 
Notes
Notes
Notes
Notes